Compass Therapeutics (CMPX) Total Liabilities: 2023-2025
Historic Total Liabilities for Compass Therapeutics (CMPX) over the last 3 years, with Sep 2025 value amounting to $21.6 million.
- Compass Therapeutics' Total Liabilities rose 101.30% to $21.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.6 million, marking a year-over-year increase of 101.30%. This contributed to the annual value of $15.2 million for FY2024, which is 81.96% up from last year.
- Per Compass Therapeutics' latest filing, its Total Liabilities stood at $21.6 million for Q3 2025, which was down 7.85% from $23.5 million recorded in Q2 2025.
- Compass Therapeutics' Total Liabilities' 5-year high stood at $23.5 million during Q2 2025, with a 5-year trough of $4.1 million in Q1 2024.
- Moreover, its 3-year median value for Total Liabilities was $10.9 million (2023), whereas its average is $13.4 million.
- In the last 5 years, Compass Therapeutics' Total Liabilities plummeted by 67.88% in 2024 and then spiked by 418.67% in 2025.
- Compass Therapeutics' Total Liabilities (Quarterly) stood at $8.3 million in 2023, then skyrocketed by 81.96% to $15.2 million in 2024, then spiked by 101.30% to $21.6 million in 2025.
- Its last three reported values are $21.6 million in Q3 2025, $23.5 million for Q2 2025, and $21.2 million during Q1 2025.